publication venue for
- Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. 2019
- Publisher Correction: Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. 2018
- Black voices in cancer research and oncology. 2024
- Fungi in cancer. 2024
- Cancer is an ancient disease: the case for better palaeoepidemiological and molecular studies.. 11. 2011
- Endoplasmic reticulum stress signals in the tumour and its microenvironment. 2020
- The epigenomics of sarcoma. 2020
- Peripheral T cell lymphomas: from the bench to the clinic. 2020
- Using immunotherapy to boost the abscopal effect. 2018
- Exercise-dependent regulation of the tumour microenvironment. 2017
- Pre-metastatic niches: organ-specific homes for metastases. 2017
- RNA splicing factors as oncoproteins and tumour suppressors. 2016
- Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. 2015
- Radioimmunotherapy of human tumours. 2015
- Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. 2014
- The evolution of the cancer niche during multistage carcinogenesis. 2013
- Neuroblastoma: developmental biology, cancer genomics and immunotherapy. 2013
- The role of mutations in epigenetic regulators in myeloid malignancies. 2012
- Antibody therapy of cancer. 2012
- Safe harbours for the integration of new DNA in the human genome. 2011
- Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. 2011
- Advances in sarcoma genomics and new therapeutic targets. 2011
- Kaposi's sarcoma and its associated herpesvirus. 2010
- Targeting the dynamic HSP90 complex in cancer. 2010
- Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers. 2010
- Translational control in cancer. 2010
- The metastatic niche: adapting the foreign soil. 2009
- Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. 2008
- The anaplastic lymphoma kinase in the pathogenesis of cancer. 2008
- Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. 2007
- Candidate mechanisms for chemotherapy-induced cognitive changes. 2007
- Occurrence of leukaemia following gene therapy of X-linked SCID. 2003
- Targeting tumours with genetically enhanced T lymphocytes. 2003
- Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? 2002
- Gli and hedgehog in cancer: tumours, embryos and stem cells. 2002
- Second cancers in survivors of childhood cancer. 2002
- Therapeutic resistance to anti-oestrogen therapy in breast cancer. 2023
- Micro-engineering and nano-engineering approaches to investigate tumour ecosystems. 2023
- Developing dietary interventions as therapy for cancer. 2022
- CRISPR in cancer biology and therapy. 2022
- Connecting copper and cancer: from transition metal signalling to metalloplasia. 2021
- A framework for advancing our understanding of cancer-associated fibroblasts. 2020
- Controversies around epithelial-mesenchymal plasticity in cancer metastasis. 2019
- Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. 2019
- The lung microenvironment: an important regulator of tumour growth and metastasis. 2019
- Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. 2018
- Interrogating open issues in cancer precision medicine with patient-derived xenografts. 2017
- Examining the utility of patient-derived xenograft mouse models. 2015
- Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. 2010
- Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. 2006
- Cancer/testis antigens, gametogenesis and cancer. 2005
- Umbilical-cord blood transplantation for the treatment of cancer. 2003